Latest filing published 16 Mar 2007 for MEDISTEM LABORATORIES, INC., €2,700.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Neil H. Riordan: trading record in brief
Neil H. Riordan is a declared insider of Medistem Laboratories, Inc., with filings sourced from SEC (Form 4). In total, 5 filings cover trades dated from 5 December 2006 to 6 March 2007.
Purchases make up the whole of the open-market record (3 purchases, €5,927). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant. So far in 2007, the count stands at 1 purchase and no sales.
A typical purchase (the median) is worth €2,628.
Most recently, on 16 March 2007, the filings show an open-market purchase worth €2,700 in Medistem Laboratories, Inc. Typically, a trade is published a median of 6 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Neil H. Riordan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 45,000 shares@ US$0.0799COMMON STOCKSEC:0001354093-07-000007:0Canonical exit: 5 Mar 2007 (T+90)
- 250,000 shares0COMMON STOCKSEC:0001354093-07-000008:0
- 150,000 shares0COMMON STOCKSEC:0000313368-07-000003:0
- 50,000 shares@ US$0.07Medistem Common StockSEC:0001350441-06-000001:0Canonical exit: 5 Mar 2007 (T+90)
- 10,000 shares@ US$0.0799Medistem Common StockSEC:0001350441-06-000001:1Canonical exit: 5 Mar 2007 (T+90)
5 of 5 declarations